LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN CARDIOVASCULAR RISK STRATIFICATION AFTER CORONARY ANGIOPLASTY IN PATIENTS WITH TYPE 2 DIABETES: WHICH DECISION RULE THRESHOLD TO CHOOSE?

LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN CARDIOVASCULAR RISK STRATIFICATION AFTER CORONARY ANGIOPLASTY IN PATIENTS WITH TYPE 2 DIABETES: WHICH DECISION RULE THRESHOLD TO CHOOSE?

The research objective is to determine the posterior probability of adverse cardiovascular events after elective coronary intervention in patients with ischemic heart disease (IHD) associated with type 2 diabetes, at high level of lipoprotein-associated phospholipase A2 (Lp-PLA2) in blood serum, as...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. T. Teplyakov, A. V. Kuznetsova, N. V. Protopopova, A. V. Andriyanova, T. E. Suslova, O. N. Nasanova, V. V. Kalyuzhin
Format:	Article
Language:	English
Published:	Siberian State Medical University (Tomsk) 2015-04-01
Series:	Бюллетень сибирской медицины
Subjects:	coronary artery disease type 2 diabetes mellitus percutaneous coronary intervention inflammation lipoprotein-associated phospholipase a2 prognosis
Online Access:	https://bulletin.ssmu.ru/jour/article/view/131
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Predictive value of serum lipoprotein-associated phospholipase A2 for coronary atherosclerotic heart disease in elderly patients with hypertension
by: Zhang Mimi, et al.
Published: (2025-03-01)

Effects of combined therapy with atorvastatin and polyunsaturated omega-3 fatty acids on lipid profile, lipoprotein-associated phospholipase A2 and thromboxane
by: G. F. Piksina, et al.
Published: (2010-10-01)

Correlation between serum lipoprotein associated phospholipase A2 level and renal damage in elders with type 2 diabetes mellitus
by: Xie Juan, et al.
Published: (2022-06-01)

INFLUENCE OF RESISTIN ON THE COURSE OF ISCHEMIC HEART DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
by: A. T. Teplyakov, et al.
Published: (2015-10-01)

Effect of plasma lipoprotein-associated phospholipase A<sub>2</sub> levels on structure and function of heart in patients undergoing maintenance hemodialysis
by: WANG Yun-qian, et al.
Published: (2016-01-01)

Correlationbetween the activity of lipoprotein-associated phospholipase A2 and blood lipid levels in hypertensive patients with different temperament and anxiety
by: G. A. Usenko, et al.
Published: (2014-12-01)

Serum lipoprotein‐associated phospholipase A2 activity in Chinese patients with systemic lupus erythematosus
by: Jie Feng, et al.
Published: (2024-12-01)

Human phospholipases A2: a functional and evolutionary analysis
by: I. I. Turnaev, et al.
Published: (2023-01-01)

Viperidae snake venom phospholipase A2 . Biochemical targets for the action of protein in the human blood circulatory system. Part 1 (review of literature)
by: L. V. Galebskaya, et al.
Published: (2022-05-01)

RELATIONSHIP OF LIPOPROTEINE-ASSOCIATED PHOSPHOLIPASE A2 WITH CORONARY AND CAROTID ATHEROSCLEROSIS IN KIRGIZ ETHNIC GROUP
by: A. G. Polupanov, et al.
Published: (2014-11-01)

Viperidae snake venom phospholipase A2. Biochemical targets in the human blood circulatory system. Review. Part 2
by: L. V. Vasina, et al.
Published: (2024-04-01)

The diagnostic value of lipoprotein-related phospholipase A2 and matrix metalloproteinase-9 in identifying patients with coronary plaque or stenosis
by: Sungur Neslihan, et al.
Published: (2025-07-01)

Lipoprotein(a), homocysteine and coronary atherosclerosis in young and middle-aged men
by: M. V. Ezhov, et al.
Published: (2008-10-01)

Value of M-type phospholipase A2 receptor in clinical diagnosis and treatment of membranous nephropathy:recent advances and current controversies
by: Wang Hui, et al.
Published: (2021-01-01)

Number of blood neutrophil granulocytes is associated with diffuse coronary involvement in patients with increased lipoprotein (a)
by: A. Yu. Filatova, et al.
Published: (2023-11-01)

Correlation Between Lipoprotein(a) and Prognosis for Coronary Artery Disease in Patients Undergoing Percutaneous Coronary Intervention
by: Azhi ShaMa, MM, et al.
Published: (2024-12-01)

SPECIFICS OF SUBFRACTIONAL SPECTRUM OF APOLIPOPROTEIN B RELATED LIPOPROTEINES IN CAROTID OR CORONARY ATHEROSCLEROSIS PATIENTS
by: N. E. Gavrilova, et al.
Published: (2016-10-01)

Study of the cytotoxic effect of secretory phospholipase A<sub>2</sub> of <i>Vipera nikolskii</i> venom on the model of HeLа and ECV340 cell lines
by: M. A. Solovyeva, et al.
Published: (2024-12-01)

Contribution of individual phospholipase A2 enzymes to the cleavage of oxidized phospholipids in human blood plasma
by: Philipp Jokesch, et al.
Published: (2025-02-01)

Differential impact of lipoprotein(a) on subclinical coronary atherosclerosis in asymptomatic individuals with and without diabetes mellitus
by: Mi-Hee Jang, et al.
Published: (2025-07-01)

Safety evaluation of the food enzyme phospholipase A2 from porcine pancreas
by: EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP), et al.
Published: (2023-04-01)

Overproduction and Characterization of Recombinant Soluble Trypanosoma brucei Phospholipase A2
by: Oluwafemi Abiodun Adepoju, et al.
Published: (2025-03-01)

Platelet-activating Factor–Acetyl Hydrolase is Associated with Dysregulated Expression of <i>Nrf2</i>-NQO1 Pathway in Metabolic Syndrome
by: Seema Garg, et al.
Published: (2025-05-01)

Long-term clinical results of coronary angioplasty with sirolimus-eluting stents in patients with Type 2 diabetes mellitus
by: K. N. Petrova, et al.
Published: (2008-10-01)

Association Between Lipoprotein(a) and Risk Factors of Atherosclerosis in Russian Population (Data of Observational ESSE-RF study)
by: S. A. Shalnova, et al.
Published: (2019-11-01)

Synthesis, molecular modelling, and biological evaluation of novel quinoxaline derivatives for treating type II diabetes
by: Fatmah Ali S. Alasmary, et al.
Published: (2024-12-01)

The correlation between anti-phospholipase A2 receptor antibodies and hypercoagulability in patients with idiopathic membranous nephropathy
by: Yunyun Liu, et al.
Published: (2024-12-01)

Changes and significance of plasma Lp-PLA<sub>2</sub> levels in hemodialysis patients with autologous arteriovenous fistula
by: CHENG Yi, et al.
Published: (2020-01-01)

ASSOCIATION OF HIGH LIPOPROTEIN(a) LEVELS WITH CORONARY ARTERY PATENCY DURING THE FIRST YEAR AFTER PERCUTANEOUS CORONARY INTERVENTIONS
by: M. V. Ezhov, et al.
Published: (2014-07-01)

Secretory phospholipase A2: a biomarker of inflammation in autoimmune, bacterial and viral diseases
by: S. P. Urazov, et al.
Published: (2022-07-01)

Low-density lipoprotein cholesterol predicts coronary artery calcification events in patients with type 2 diabetes: a longitudinal study
by: Zhi Zou, et al.
Published: (2025-02-01)

Association of the Monocyte to High-Density Lipoprotein Cholesterol Ratio and Neutrophil to High-Density Lipoprotein Cholesterol Ratio With the Severity of New-Onset Coronary Artery Disease
by: Shu H, et al.
Published: (2025-01-01)

A Lipidomic Approach to Studying the Downregulation of Free Fatty Acids by Cytosolic Phospholipase A<sub>2</sub> Inhibitors
by: Asimina Bourboula, et al.
Published: (2025-04-01)

Inhibiting the Interaction Between Phospholipase A2 and Phospholipid Serine as a Potential Therapeutic Method for Pneumonia
by: Jianyu Wang, et al.
Published: (2025-07-01)

SUBFRACTION DISTRIBUTION OF APO B-CONTAINING LIPOPROTEINS DEPENDING ON THE ACHIEVEMENT OF THE TARGET LEVEL OF LOW DENSITY LIPOPROTEINS UNDER STATINS THERAPY IN PATIENTS WITH CORONARY ATHEROSCLEROSIS
by: I. N. Ozerova, et al.
Published: (2017-12-01)

Lipoprotein (a) polymorphism as a risk factor of coronary and carotid atherosclerosis and its complications in women
by: O. I. Afanasyeva, et al.
Published: (2010-12-01)

Hindlll polymorphism of lipoprotein lipase gene in patients with acute coronary syndrome
by: R. T. Saygitov, et al.
Published: (2008-12-01)

Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody–Positive Primary Membranous Nephropathy
by: Brad H. Rovin, et al.
Published: (2024-09-01)

Proteomics Analysis of the Regulatory Mechanism of the Calcium-Independent Phospholipase A2 Activity of Peroxiredoxin 6 on Beef Tenderization
by: LIU Jitong, WANG Xinyi, ZHANG Yimin, ZHU Lixian, LIANG Rongrong, MAO Yanwei
Published: (2025-06-01)

The Effect of Different Lipoproteins on the Severity of Coronary Atherosclerosis and Relation between them in Patients in Kurdistan
by: Marewan Hawil Saka, et al.
Published: (2023-04-01)